Our study, to the best of our knowledge, has shown for the first time that the level (%) of circulating FOXP3+ Tregs predicted the likely response to NAC – high levels resulting in poor pathological responses in the cancers in the breast. This evidence concerns the gene FOXP3 and cancer.